EndoShape reports raising $1.8M in new funds
BOULDER — Medical-device company EndoShape Inc., has raised about $1.8 million in new funding, according to a recent filing made with the U.S. Securities and Exchange Commission.
A company official on Wednesday said he couldn’t comment on the funding at this time.
According to the filing, the new funds add to a funding round first disclosed last year that had reached about $1.2 million at that point.
SPONSORED CONTENT
Platte River’s path to a clean, reliable energy future
In 2018, Platte River’s Board of Directors passed a Resource Diversification Policy, setting a new course for how Platte River provides energy.
EndoShape’s Medusa MultiCoil is a device used for the embolization, or blocking, of blood vessels. It’s used to close off vessels that might be ruptured and causing internal bleeding or vessels that are feeding a tumor.
EndoShape received U.S. Food and Drug Administration approval for the device in 2013. That clearance was followed by a $5.9 million funding round in 2014.
BOULDER — Medical-device company EndoShape Inc., has raised about $1.8 million in new funding, according to a recent filing made with the U.S. Securities and Exchange Commission.
A company official on Wednesday said he couldn’t comment on the funding at this time.
According to the filing, the new funds add to a funding round first disclosed last year that had reached about $1.2 million at that point.
EndoShape’s Medusa MultiCoil is a device used for the embolization, or blocking, of blood vessels. It’s used to close off vessels that might be ruptured and causing internal bleeding or vessels that are feeding a tumor.
EndoShape…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!